Clinical Trials
LTO Network and Sphereon Partner With Triall for World’s First Application of Blockchain Technology to COVID-19 Clinical Trials
Dutch blockchain companies LTO Network and Sphereon have partnered with Triall, experts in the realm of blockchain and clinical research, to deliver the first...
Drug Research
Arecor Therapeutics Signs Formulation Agreement with Intas Pharmaceuticals
Arecor Therapeutics plc, a biopharmaceutical group advancing therapies to enable healthier lives, has signed a formulation agreement with Intas Pharmaceuticals Ltd.
Under this agreement, Arecor...
Packaging & Labelling
SkyCell partners with All Nippon Airways to support Japanese pharma market
At SkyCell, we have expanded our airline partnerships into Japan by partnering with All Nippon Airways (ANA), the country’s largest airline. This collaboration will...
News
DoKaSch Temperature Solution opens new service station in India
DoKaSch Temperature Solutions has opened a new service station in India. It is located at GMR Hyderabad Air Cargo terminal.
Strategically, the Hyderabad Airport location...
News
Hetero obtains DCGI approval to produce Roche’s Covid-19 drug in India
Indian drug developer Hetero said it has received emergency use approval from the country's health authorities to make a generic version of Roche Holding...
Clinical Trials
Reliance obtains DCGI approval to conduct Phase I Covid-19 vaccine trial
Reliance Life Sciences has obtained approval from the Drugs Controller General of India (DCGI) to carry out a Phase I clinical trial of its...
Clinical Trials
Sorrento begin patient enrollment in phase 2 study of COVI-MSC to treat Covid-19 associated ARD in ICU patients
Sorrento Therapeutics, Inc. announced the start of enrollment in its Phase 2 efficacy study of human allogeneic adipose-derived mesenchymal stem cells (COVI-MSC™) for patients...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read